Furthermore, abnormally low liver CPS1 activity has been reported in patients with genetically demonstrated NAGSD[29,191] and in the hyperinsulinism-hyperammonemia syndrome[192] (a defect involving glutamate dehydrogenase). The gene discussed is CPS1; the disease is hyperammonemia due to N-acetylglutamate synthase deficiency.